Condition: Diabetes Mellitus, Type 2 · Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
The objective of this study is to evaluate feasibility, safety, and efficacy of endoscopic DMR Treatment Paradigm 1 (compared to sham) and to evaluate feasibility, safety, and efficacy of re-treatment with DMR at 24 weeks (compared to baseline and a single DMR procedure) in patients with type 2 diabetes with non-insulin glucose lowering medications.
This description comes directly from the study's public registry record.
Kim van den Hoek, MD · +31621357593 · k.vandenhoek@amsterdamumc.nl
Celine BE Busch, MD · +31621357593 · c.b.busch@amsterdamumc.nl
Always discuss trial participation with your own doctor first.
| Amsterdam UMC, locatie VUmc | Amsterdam, Netherlands | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06092476